BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38015774)

  • 21. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal trends in loss of life expectancy after a cancer diagnosis among the Australian population.
    Kou K; Dasgupta P; Cramb SM; Yu XQ; Andersson TM; Baade PD
    Cancer Epidemiol; 2020 Apr; 65():101686. PubMed ID: 32062407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment.
    Ko CY; Maggard M; Livingston EH
    J Surg Res; 2003 Sep; 114(1):1-5. PubMed ID: 13678691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer mortality surveillance--United States, 1990-2000.
    Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
    MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of reporting delay and reporting error on cancer incidence rates and trends.
    Clegg LX; Feuer EJ; Midthune DN; Fay MP; Hankey BF
    J Natl Cancer Inst; 2002 Oct; 94(20):1537-45. PubMed ID: 12381706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Loss in Expectation of Life due to Early-Onset Mild Cognitive Impairment and Early-Onset Dementia in Norway.
    Strand BH; Knapskog AB; Persson K; Holt Edwin T; Bjertness E; Engedal K; Selbaek G
    Dement Geriatr Cogn Disord; 2019; 47(4-6):355-365. PubMed ID: 31319412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy.
    Minami CA; Jin G; Freedman RA; Schonberg MA; King TA; Mittendorf EA
    Ann Surg Oncol; 2024 Feb; 31(2):920-930. PubMed ID: 37851196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rise in the number of long-term survivors from different diseases can slow the increase in life expectancy of the total population.
    Ebeling M; Meyer AC; Modig K
    BMC Public Health; 2020 Oct; 20(1):1523. PubMed ID: 33028250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
    Henley SJ; King JB; German RR; Richardson LC; Plescia M;
    MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the impact of socioeconomic differences in breast cancer survival in England and Wales: avoidable deaths and potential gain in expectation of life.
    Rutherford MJ; Andersson TM; Møller H; Lambert PC
    Cancer Epidemiol; 2015 Feb; 39(1):118-25. PubMed ID: 25435402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America.
    Karalexi MA; Baka M; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Polychronopoulou S; Stiakaki E; Moschovi M; Hatzipantelis E; Kourti M; Graphakos S; Pombo-de-Oliveira MS; Adami HO; Petridou ET
    Eur J Cancer; 2016 Nov; 67():183-190. PubMed ID: 27677054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic trends in life expectancy and life years lost over five decades in patients from the SEER database with chronic myeloid leukaemia.
    Shivarov V; Grigorova D
    Br J Haematol; 2022 Jul; 198(2):e23-e25. PubMed ID: 35415917
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidemiology of cancer in the United States.
    Cresanta JL
    Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Illustration of different modelling assumptions for estimation of loss in expectation of life due to cancer.
    Andersson TM; Rutherford MJ; Lambert PC
    BMC Med Res Methodol; 2019 Jul; 19(1):145. PubMed ID: 31288739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.
    Islami F; Ward EM; Sung H; Cronin KA; Tangka FKL; Sherman RL; Zhao J; Anderson RN; Henley SJ; Yabroff KR; Jemal A; Benard VB
    J Natl Cancer Inst; 2021 Nov; 113(12):1648-1669. PubMed ID: 34240195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reference-Adjusted Loss in Life Expectancy for Population-Based Cancer Patient Survival Comparisons-with an Application to Colon Cancer in Sweden.
    Andersson TM; Rutherford MJ; Møller B; Lambert PC; Myklebust TÅ
    Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1720-1726. PubMed ID: 35700010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.
    Dignam JJ; Huang L; Ries L; Reichman M; Mariotto A; Feuer E
    Cancer; 2009 Nov; 115(22):5272-83. PubMed ID: 19670456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreasing trend in mortality of chronic myelogenous leukemia patients after introduction of imatinib in Japan and the U.S.
    Chihara D; Ito H; Matsuda T; Katanoda K; Shibata A; Saika K; Sobue T; Matsuo K
    Oncologist; 2012; 17(12):1547-50. PubMed ID: 22971523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
    Murray CJ; Lopez AD
    Lancet; 1997 May; 349(9064):1498-504. PubMed ID: 9167458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.